Optimum Energy a leading supplier of energy optimization solutions, and Tignis, Inc. a pioneer in AI/ML solutions for advanced process control, today announced a new multi-year worldwide

C2N Diagnostics, a leader in advanced brain health diagnostics, recognizes the landmark decision by the U.S. Food and Drug Administration to approve anti-amyloid antibody lecanemab

Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, is proud to announce the release of new V series Glass-Free Flat Panel Detectors (FPD) which are now compatible with our general radiography systems..

Sirnaomics Ltd. a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced that the Company has established a strategic partnership

Methodist Le Bonheur Healthcare expands services at its newly renovated Methodist Comprehensive Breast Center and Diagnostic Center in midtown Memphis, which offers patients

Jacobio Pharma, a clinical-stage oncology company drugging the undruggable targets, today announced its novel KRAS G12C inhibitor glecirasib?s pivotal study for pancreatic cancer has been

RareStone Group, a rare disease-focused company aiming to establish the first rare disease ecosystem in China, announced that on June 30, the Chinese National Medical Products

Findings from a recent study demonstrate that medical AI solutions with only high diagnostic accuracy can significantly improve the reading performance of radiologists.

Celltrion USA today announced the launch of Yuflyma, a high-concentration and citrate-free formulation of Humira biosimilar, providing an alternative option for patients. Yuflyma is indicated

Alma, the world leader and innovator in providing energy-based medical and aesthetic solutions and a wholly-owned company by Sisram Medical (1696.HK), announced today that it has completed